Cure8 research brief
Why This Matters
Dual-energy CT quantification of creeping fat could offer a measurable imaging biomarker that reflects transmural inflammation and fibrosis in Crohn’s disease, potentially improving monitoring beyond mucosal healing.
Who Should Pay Attention
Clinicians (gastroenterologists, radiologists), researchers studying IBD biomarkers and imaging, and patients interested in advanced IBD monitoring options.
Study Snapshot
What To Know
The article reports that dual-energy computed tomography with multi-material decomposition can objectively measure creeping fat in Crohn’s disease and that this measure correlates with clinical, endoscopic, histologic, and molecular indices of activity.
The piece is presented as an invited editorial in World Journal of Radiology and summarizes the potential role of this imaging technique for assessing transmural and mesenteric disease. This is an editorial/article in press rather than a completed large prospective validation.
It highlights promise for a new radiologic biomarker but does not replace current standard assessment methods.
Keep In Mind
This is an invited editorial/article in press summarizing the technique and its potential correlations; it does not constitute definitive validation. Further prospective or multicenter studies will be needed to confirm clinical utility.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.